www.fdanews.com/articles/206205-ema-lists-rare-spinal-condition-as-side-effect-of-astrazenecas-covid-19-shot
EMA Lists Rare Spinal Condition as Side Effect of AstraZeneca’s COVID-19 Shot
January 18, 2022
The European Medicines Agency (EMA) has recommended adding a warning about the risk of a rare form of spinal inflammation — transverse myelitis — to the list of adverse events associated with AstraZeneca’s COVID-19 vaccine.
The EMA’s safety committee conducted a review of globally reported cases, including those in its adverse events database, EudraVigilance, and concluded that “a causal relationship” between the shot and side effect is “at least a reasonable possibility.”
The EMA previously recommended adding transverse myelitis to the list of possible side effects linked with Johnson & Johnson’s (J&J) COVID-19 vaccine.